RxDoctor Payments Data

Barton Warren, MD

Family Medicine · Richland, MONPI 1376674408

Payments from drug & device makers

$496in general payments, 2019–2025

Across 34 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$222
  • AstraZeneca$69
  • Lilly USA, LLC$33
  • Sanofi Pasteur Inc.$24
  • Apria Healthcare LLC$24
  • Alkermes, Inc.$23
  • plus $100 from 8 others

What the payments were for

  • Food & beverage$495100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$18,128
Medicare patients
517
Services billed
1,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide132$137,593
TrulicityDulaglutide111$113,626
Trelegy ElliptaFluticasone/Umeclidin/Vilanter136$103,187
Humira PenAdalimumab12$96,695
EliquisApixaban223$84,384
JardianceEmpagliflozin95$61,656
JanuviaSitagliptin Phosphate81$49,993
Combivent RespimatIpratropium/Albuterol Sulfate53$26,066
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog40$24,520
LinzessLinaclotide49$24,175
FarxigaDapagliflozin Propanediol27$22,019
MounjaroTirzepatide18$19,252
Lantus SolostarInsulin Glargine,hum.Rec.Anlog130$16,676
MyrbetriqMirabegron49$16,333
SymbicortBudesonide/Formoterol Fumarate56$15,964

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$137,593132 claims
Lilly USA, LLCTrulicity, Mounjaro$33$132,878129 claims
MerckJanuvia$16$49,99381 claims
AstraZenecaFarxiga, Symbicort, Nexium$69$41,86797 claims
AbbVieLinzess, Savella$222$30,82063 claims
Johnson & JohnsonXarelto$18$12,36713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Richland

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →